Laboratory and hospital teams returned to psilocybin because measured doses plus psychological support changed depression scores for some people who had already failed standard antidepressants—and because related work pointed toward relief in certain anxiety states and, more cautiously, pain-related suffering. Psilocybin has shown promise in treating chronic pain, depression, and anxiety disorders inside that supervised […]